Literature DB >> 15299058

In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.

JianFei Guo1, Kotaro Higashi, Hajime Yokota, Yosinobu Nagao, Yoshimichi Ueda, Yuko Kodama, Manabu Oguchi, Suzuka Taki, Hisao Tonami, Itaru Yamamoto.   

Abstract

UNLABELLED: It has been reported that (18)F-FDG uptake, lactate concentration, and choline concentration are good indicators of malignant grade in several different kinds of tumors. In this study, we investigated the correlation between (18)F-FDG uptake in (18)F-FDG PET imaging, lactate concentration and choline concentration measured by in vitro (1)H magnetic resonance spectroscopy (MRS), and survival probabilities in human lung adenocarcinoma.
METHODS: Nineteen patients with lung adenocarcinoma underwent (18)F-FDG PET before surgery. The (1)H MRS spectra were obtained in vitro from methanol-chloroform-water extracts of lung adenocarcinomas and normal lungs. The ratios of the lactate (R(lac)) or choline (R(cho)) concentration of lung adenocarcinoma to normal lung from the same patient were correlated with the mean standardized uptake value (SUV). The Kaplan-Meier life table method was used to analyze the relationship between (18)F-FDG uptake, R(lac), R(cho), and patient survival probabilities.
RESULTS: There was no significant correlation between mean SUV and R(lac) or R(cho) in patients with lung adenocarcinoma. An SUV > 5 means poorer survival probabilities in patients with lung adenocarcinoma (P = 0.004). A higher R(lac) probably indicates a trend for patients with lung adenocarcinoma to have poorer survival probabilities; however, R(cho) is not an indicator of survival probability. (18)F-FDG uptake significantly correlated with cell differentiation (P = 0.007), whereas R(lac) and R(cho) had no correlation with it.
CONCLUSION: No significant correlation was found between SUV and R(lac) or R(cho) in patients with lung adenocarcinoma. Compared with R(lac) and R(cho) measured by in vitro MRS, (18)F-FDG uptake is a better indicator of prognosis in patients with lung adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15299058

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  A robust coregistration method for in vivo studies using a first generation simultaneous PET/MR scanner.

Authors:  Thomas S C Ng; Daniel Procissi; Yibao Wu; Russell E Jacobs
Journal:  Med Phys       Date:  2010-05       Impact factor: 4.071

2.  Can nuclear magnetic resonance (NMR) spectroscopy reveal different metabolic signatures for lung tumours?

Authors:  Iola F Duarte; Cláudia M Rocha; António S Barros; Ana M Gil; Brian J Goodfellow; Isabel M Carreira; João Bernardo; Ana Gomes; Vitor Sousa; Lina Carvalho
Journal:  Virchows Arch       Date:  2010-10-13       Impact factor: 4.064

Review 3.  Methodological Developments for Metabolic NMR Spectroscopy from Cultured Cells to Tissue Extracts: Achievements, Progress and Pitfalls.

Authors:  Norbert W Lutz; Monique Bernard
Journal:  Molecules       Date:  2022-06-30       Impact factor: 4.927

4.  Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells.

Authors:  Sridhar Nimmagadda; Kristine Glunde; Martin G Pomper; Zaver M Bhujwalla
Journal:  Neoplasia       Date:  2009-05       Impact factor: 5.715

5.  Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue-serum pairs.

Authors:  K W Jordan; C B Adkins; L Su; E F Halpern; E J Mark; D C Christiani; L L Cheng
Journal:  Lung Cancer       Date:  2009-06-25       Impact factor: 5.705

6.  Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer.

Authors:  Eun Jeong Ban; Daham Kim; Jin Kyong Kim; Sang-Wook Kang; Jandee Lee; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Kunhong Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.